Editas Medicine (EDIT) Capital Leases (2016 - 2018)

Editas Medicine (EDIT) has 3 years of Capital Leases data on file, last reported at $32.4 million in Q4 2018.

• Capital Leases for Q4 2018 came in at $32.4 million, down 3.03% year-over-year; the trailing twelve-month figure through Dec 2018 was $32.4 million (down 3.03% YoY), and the FY2018 annual result was $32.4 million, down 3.03% from the prior year.
• Capital Leases eased to $32.4 million in Q4 2018 per EDIT's latest filing, from $32.7 million in the prior quarter.
• Over five years, Capital Leases peaked at $35.1 million in Q4 2016 and troughed at $11.6 million in Q1 2016.
• A 3-year average of $30.6 million and a median of $33.1 million in 2018 frame the typical range for Capital Leases.
• On a YoY basis, Capital Leases climbed as much as 191.26% in 2017 and fell as far as 4.74% in 2017.
• A 3-year view of Capital Leases shows it stood at $35.1 million in 2016, then dropped by 4.74% to $33.4 million in 2017, then slipped by 3.03% to $32.4 million in 2018.
• Business Quant data shows EDIT's Capital Leases at $32.4 million in Q4 2018, $32.7 million in Q3 2018, and $32.9 million in Q2 2018.